We are live on ! Find out more
UFF

USA Financial Formulas Portfolio holdings

AUM $531M
1-Year Est. Return 28.6%
This Fund
S&P 500
This Quarter Est. Return
+11.66%
1 Year Est. Return
+28.6%
3 Year Est. Return
+77.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$572M
AUM Growth
+$505M
Cap. Flow
+$466M
Cap. Flow %
81.59%
Top 10 Hldgs %
75.29%
Holding
570
New
76
Increased
157
Reduced
78
Closed
237

Top Buys

Rank Stock Value
1
IJK icon
iShares S&P Mid-Cap 400 Growth ETF
IJK
+$61.8M
2
IVW icon
iShares S&P 500 Growth ETF
IVW
+$60.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$60.8M
4
IVE icon
iShares S&P 500 Value ETF
IVE
+$60.6M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$60.4M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.22M
2
BIIB icon
Biogen
BIIB
+$2.09M
3
GILD icon
Gilead Sciences
GILD
+$2.04M
4
ROST icon
Ross Stores
ROST
+$1.53M
5
MNST icon
Monster Beverage
MNST
+$1.53M

Sector Composition

Rank Sector Weight
1 Technology 7.26%
2 Industrials 3.12%
3 Communication Services 2.93%
4 Financials 2.5%
5 Consumer Discretionary 2.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCHP icon
251
Microchip Technology
MCHP
$46.2B
$10.9K ﹤0.01%
121
-10
-8% -$814
BIIB icon
252
Biogen
BIIB
$30.6B
$10.9K ﹤0.01%
42
-8,504
-100% -$2.09M
FDX icon
253
FedEx
FDX
$75.1B
$9.36K ﹤0.01%
37
-959
-96% -$244K
ACGL icon
254
Arch Capital
ACGL
$33.7B
$9.28K ﹤0.01%
125
-14,801
-99% -$1.21M
CLH icon
255
Clean Harbors
CLH
$16.2B
$7.16K ﹤0.01%
41
-1,555
-97% -$255K
IR icon
256
Ingersoll Rand
IR
$33.9B
$6.96K ﹤0.01%
90
-3,941
-98% -$269K
JBL icon
257
Jabil
JBL
$36B
$6.88K ﹤0.01%
54
-881
-94% -$112K
PH icon
258
Parker-Hannifin
PH
$136B
$6.45K ﹤0.01%
14
-585
-98% -$244K
LLY icon
259
Eli Lilly
LLY
$1.05T
$5.83K ﹤0.01%
10
-246
-96% -$144K
DHI icon
260
D.R. Horton
DHI
$42.1B
$5.17K ﹤0.01%
34
-1,336
-98% -$165K
CW icon
261
Curtiss-Wright
CW
$25.6B
$4.9K ﹤0.01%
22
-410
-95% -$85.8K
EME icon
262
Emcor
EME
$36.3B
$4.74K ﹤0.01%
22
-886
-98% -$186K
OLLI icon
263
Ollie's Bargain Outlet
OLLI
$4.87B
$4.4K ﹤0.01%
58
-1,393
-96% -$105K
TTD icon
264
Trade Desk
TTD
$6.48B
$4.25K ﹤0.01%
+59
New +$4.33K
BSX icon
265
Boston Scientific
BSX
$71.3B
$4.22K ﹤0.01%
73
-21,849
-100% -$1.17M
FTI icon
266
TechnipFMC
FTI
$27.2B
$4.19K ﹤0.01%
+208
New +$4.26K
OHI icon
267
Omega Healthcare
OHI
$14.7B
$4.17K ﹤0.01%
+136
New +$4.36K
AME icon
268
Ametek
AME
$58B
$4.12K ﹤0.01%
25
– –
IEF icon
269
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
$4.05K ﹤0.01%
42
-623
-94% -$57.6K
AGG icon
270
iShares Core US Aggregate Bond ETF
AGG
$138B
$3.97K ﹤0.01%
40
-356
-90% -$33.9K
CPAY icon
271
Corpay
CPAY
$25.6B
$3.96K ﹤0.01%
14
-895
-98% -$222K
IAU icon
272
iShares Gold Trust
IAU
$67.3B
$3.9K ﹤0.01%
100
-1,020
-91% -$38.2K
SYK icon
273
Stryker
SYK
$130B
$3.89K ﹤0.01%
13
– –
LW icon
274
Lamb Weston
LW
$7.18B
$3.89K ﹤0.01%
36
-8,310
-100% -$800K
SHY icon
275
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$3.86K ﹤0.01%
47
-442
-90% -$35.9K
9 10
11
12 13

Similar funds

EPA
Element Pointe Advisors Miami, Florida $530M AUM 16.87% 1-Year Est. Return
TM
Taproot Management New York $530M AUM
KI
Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return
PWS
Proactive Wealth Strategies Marietta, Georgia $532M AUM 21.29% 1-Year Est. Return
SLC
Second Line Capital Metairie, Louisiana $528M AUM 16.68% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $534M AUM 22.94% 1-Year Est. Return
MKA
M. Kulyk & Associates Decatur, Georgia $536M AUM 18.28% 1-Year Est. Return

USA Financial Formulas's Q4 2023 Portfolio in Review

As of Q4 2023, USA Financial Formulas held 570 positions worth $572M, up 754% from $66.9M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

USA Financial Formulas deployed $466M of net new capital in Q4 2023, opening 76 new positions and adding to 157 existing holdings. Its largest new stake was iShares S&P 500 Growth ETF: 855,439 shares worth $64.2M.

By sector, the portfolio is most concentrated in Technology at 7.3% of assets, down from 17% a quarter earlier, followed by Industrials and Communication Services.

On the sell side, the largest reduction was Biogen, an estimated $2.09M trimmed.

  • USA Financial Formulas's largest Q4 2023 buy was iShares S&P 500 Growth ETF: 855,439 shares worth $64.2M.
  • USA Financial Formulas added most to iShares S&P Mid-Cap 400 Growth ETF in Q4 2023, an estimated $61.8M increase.
  • USA Financial Formulas's biggest Q4 2023 reduction was Biogen, cutting an estimated $2.09M.
  • USA Financial Formulas fully exited Regeneron Pharmaceuticals in Q4 2023, selling an estimated $2.22M.
  • USA Financial Formulas's ten largest holdings make up 75% of its $572M portfolio in Q4 2023.
  • USA Financial Formulas opened 76 new positions and closed 237 in Q4 2023.
  • USA Financial Formulas's portfolio value rose 754% quarter-over-quarter to $572M.

Based on USA Financial Formulas's 13F filing for Q4 2023, filed 7 Feb 2024.